Q32 Bio (QTTB) Cash from Operations (2017 - 2026)

Q32 Bio's Cash from Operations history runs 10 years deep, the most recent figure standing at 6343000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 49.18% year-over-year to 6343000.0 in Q1 2026; TTM through Mar 2026 was 27404000.0, a 58.25% increase from a year earlier, with the FY2025 full-year figure at 33543000.0, up 50.46% from the prior year.
• Cash from Operations slipped to 6343000.0 in Q1 2026 per QTTB's latest filing, from 6180000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 15901000.0 in Q3 2023 and bottomed at 30846000.0 in Q2 2022.
• The 5-year median for Cash from Operations is 12482000.0 (2025), against an average of 14114058.82.
• Across the five-year window, Cash from Operations surged 163.78% in 2023 and sank 222.77% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 27199000.0 in 2022, then jumped by 60.61% to 10715000.0 in 2023, then declined by 6.65% to 11428000.0 in 2024, then surged by 45.92% to 6180000.0 in 2025, then retreated by 2.64% to 6343000.0 in 2026.
• Per Business Quant, the three latest QTTB Cash from Operations figures stand at 6343000.0 (Q1 2026), 6180000.0 (Q4 2025), and 4230000.0 (Q3 2025).